Shalby Limited Net Assets
Shalby Limited net assets. Based on the latest financial reports, Shalby Limited (SHALBY) has net assets worth Rs10.06 Billion INR (≈ $108.76 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs18.39 Billion ≈ $198.89 Million USD) and total liabilities (Rs8.33 Billion ≈ $90.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Shalby Limited (SHALBY) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs10.06 Billion |
| % of Total Assets | 54.68% |
| Annual Growth Rate | 18.88% |
| 5-Year Change | 14.78% |
| 10-Year Change | 265.08% |
| Growth Volatility | 43.8 |
Net Assets of Shalby Limited (2012–2026)
Net assets of Shalby Limited from 2012 to 2026. This chart illustrates how Shalby Limited's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Shalby Limited to measure how much of total assets are equity-financed.
Annual Net Assets for Shalby Limited (2012–2026)
The table below shows the annual net assets of Shalby Limited from 2012 to 2026. For live market cap and overall valuation, see market value of Shalby Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs10.06 Billion ≈ $108.76 Million |
+1.04% |
| 2025-03-31 | Rs9.95 Billion ≈ $107.64 Million |
-1.24% |
| 2024-03-31 | Rs10.08 Billion ≈ $108.99 Million |
+8.64% |
| 2023-03-31 | Rs9.28 Billion ≈ $100.32 Million |
+5.87% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.76 Million |
+4.97% |
| 2021-03-31 | Rs8.35 Billion ≈ $90.27 Million |
+4.44% |
| 2020-03-31 | Rs7.99 Billion ≈ $86.43 Million |
+2.49% |
| 2019-03-31 | Rs7.80 Billion ≈ $84.34 Million |
+2.41% |
| 2018-03-31 | Rs7.62 Billion ≈ $82.35 Million |
+176.43% |
| 2017-03-31 | Rs2.75 Billion ≈ $29.79 Million |
+24.27% |
| 2016-03-31 | Rs2.22 Billion ≈ $23.97 Million |
+29.81% |
| 2015-03-31 | Rs1.71 Billion ≈ $18.47 Million |
+19.08% |
| 2014-03-31 | Rs1.43 Billion ≈ $15.51 Million |
+35.63% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.43 Million |
+18.40% |
| 2012-03-31 | Rs892.99 Million ≈ $9.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shalby Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 886.2% over the analyzed period, indicating profitable operations and earnings retention.
Shalby Limited Net Assets Breakdown (March 2026)
Shalby Limited net assets breakdown by equity component as of March 2026.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs4.82 Billion | 47.90% |
| Common Stock | Rs1.08 Billion | 10.70% |
| Other Comprehensive Income | Rs-228.65 Million | -2.27% |
| Other Components | Rs4.39 Billion | 43.68% |
| Total Equity | Rs10.05 Billion | 100.00% |
Shalby Limited Competitors by Market Cap
The table below lists competitors of Shalby Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bera Holding AS
IS:BERA
|
$140.32 Million |
|
Wintermar Offshore Marine Tbk
JK:WINS
|
$140.33 Million |
|
Purple Capital Ltd
JSE:PPE
|
$140.35 Million |
|
Hamat Group Ltd
TA:HAMAT
|
$140.39 Million |
|
Shieh Yih Machinery Industry Co Ltd
TWO:4533
|
$140.26 Million |
|
LBS Bina Group Bhd
KLSE:5789
|
$140.25 Million |
|
Bank Agris Tbk
JK:AGRS
|
$140.23 Million |
|
India Pesticides Limited
NSE:IPL
|
$140.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shalby Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 9,921,880,000 to 10,052,340,000, a change of 130,460,000 (1.3%).
- Net income of 373,890,000 contributed positively to equity growth.
- New share issuances of 320,000 increased equity.
- Other comprehensive income decreased equity by 248,719,998.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs373.89 Million | +3.72% |
| Share Issuances | Rs320.00K | +0.0% |
| Other Comprehensive Income | Rs-248.72 Million | -2.47% |
| Other Changes | Rs4.97 Million | +0.05% |
| Total Change | Rs- | 1.31% |
Book Value vs Market Value Analysis
This analysis compares Shalby Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.39x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.47x to 1.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-03-31 | Rs7.80 | Rs120.64 | x |
| 2013-03-31 | Rs9.44 | Rs120.64 | x |
| 2014-03-31 | Rs13.04 | Rs120.64 | x |
| 2015-03-31 | Rs15.59 | Rs120.64 | x |
| 2016-03-31 | Rs20.49 | Rs120.64 | x |
| 2017-03-31 | Rs25.50 | Rs120.64 | x |
| 2018-03-31 | Rs80.70 | Rs120.64 | x |
| 2019-03-31 | Rs72.20 | Rs120.64 | x |
| 2020-03-31 | Rs73.99 | Rs120.64 | x |
| 2021-03-31 | Rs77.28 | Rs120.64 | x |
| 2022-03-31 | Rs81.13 | Rs120.64 | x |
| 2023-03-31 | Rs86.36 | Rs120.64 | x |
| 2024-03-31 | Rs92.45 | Rs120.64 | x |
| 2025-03-31 | Rs92.50 | Rs120.64 | x |
| 2026-03-31 | Rs86.84 | Rs120.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shalby Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.72%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.28%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.83x
- Recent ROE (3.72%) is below the historical average (11.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 30.10% | 14.25% | 1.70x | 1.24x | Rs169.24 Million |
| 2013 | 16.78% | 7.60% | 1.48x | 1.49x | Rs69.11 Million |
| 2014 | 27.70% | 15.08% | 1.19x | 1.54x | Rs249.40 Million |
| 2015 | 15.28% | 9.34% | 0.78x | 2.09x | Rs88.90 Million |
| 2016 | 16.98% | 12.94% | 0.56x | 2.35x | Rs154.53 Million |
| 2017 | 22.72% | 19.23% | 0.45x | 2.61x | Rs350.21 Million |
| 2018 | 5.64% | 11.20% | 0.40x | 1.27x | Rs-332.21 Million |
| 2019 | 4.06% | 6.87% | 0.49x | 1.20x | Rs-463.18 Million |
| 2020 | 3.45% | 5.67% | 0.50x | 1.21x | Rs-523.30 Million |
| 2021 | 5.08% | 9.84% | 0.43x | 1.19x | Rs-410.69 Million |
| 2022 | 6.18% | 7.74% | 0.59x | 1.36x | Rs-335.07 Million |
| 2023 | 7.30% | 8.41% | 0.63x | 1.38x | Rs-250.68 Million |
| 2024 | 8.40% | 9.00% | 0.58x | 1.61x | Rs-159.60 Million |
| 2025 | 0.63% | 0.57% | 0.64x | 1.72x | Rs-929.97 Million |
| 2026 | 3.72% | 3.28% | 0.62x | 1.83x | Rs-631.34 Million |
Industry Comparison
This section compares Shalby Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $24,510,790,154
- Average return on equity (ROE) among peers: 8.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shalby Limited (SHALBY) | Rs10.06 Billion | 30.10% | 0.83x | $140.28 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $16.78 Billion | 7.97% | 0.95x | $13.14 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $48.60 Billion | 8.74% | 2.06x | $6.42 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.69 Billion | 15.67% | 0.72x | $117.74 Million |
| Healthcare Global Enterprises Limited (HCG) | $4.90 Billion | 4.52% | 1.50x | $945.46 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $11.69 Billion | 15.11% | 0.10x | $911.69 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $-1.38 Billion | 0.00% | 0.00x | $3.04 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $575.79 Million | 7.08% | 0.10x | $24.55 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $107.47 Billion | 13.42% | 0.60x | $9.05 Billion |
| Max India Limited (MAXIND) | $13.94 Billion | -3.31% | 0.70x | $89.67 Million |
| Global Health Limited (MEDANTA) | $39.84 Billion | 13.97% | 0.48x | $3.69 Billion |
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, Paediatric orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardio… Read more